Cargando…
Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
Cardiac hypertrophy initially serves as an adaptive response to physiological and pathological stimuli. Sustained hypertrophy progress to pathological cardiac hypertrophy, cardiac fibrosis and ultimately lead to heart failure, one of the leading medical causes of mortality worldwide. Intervention of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393479/ https://www.ncbi.nlm.nih.gov/pubmed/36003513 http://dx.doi.org/10.3389/fphar.2022.940768 |
_version_ | 1784771277548945408 |
---|---|
author | Chen, Yan Zhou, Junteng Wei, Zisong Cheng, Yue Tian, Geer Quan, Yue Kong, Qihang Wu, Wenchao Liu, Xiaojing |
author_facet | Chen, Yan Zhou, Junteng Wei, Zisong Cheng, Yue Tian, Geer Quan, Yue Kong, Qihang Wu, Wenchao Liu, Xiaojing |
author_sort | Chen, Yan |
collection | PubMed |
description | Cardiac hypertrophy initially serves as an adaptive response to physiological and pathological stimuli. Sustained hypertrophy progress to pathological cardiac hypertrophy, cardiac fibrosis and ultimately lead to heart failure, one of the leading medical causes of mortality worldwide. Intervention of pathological cardiac hypertrophy can effectively reduce the occurrence of heart failure. Abundant factors, such as adrenergic, angiotensin, and endothelin (ET-1) receptors, have been shown to participate in the regulation of pathological cardiac hypertrophy. Recently, an increasing number of studies have indicated that circRNA and circRNA-miRNA–mRNA network regulation is indispensable for the posttranscriptional regulation of mRNA in cardiac hypertrophy. In our study, the morphological, cardiac function and pathological changes during cardiac hypertrophy were investigated. RNA sequencing identified 93 circRNAs that were differentially expressed in the TAC_2w group, and 55 circRNAs in the TAC_4w group compared with the sham group. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses identified several significant pathways, including hypertrophic cardiomyopathy, extracellular matrix (ECM)-receptor interaction and focal adhesion. Coexpression analyses were performed for differentially expressed circRNAs and differentially expressed mRNAs. Based on gene set enrichment analysis (GSEA), 8 circRNAs (mmu-Nfkb1_0001, mmu-Smad4_0007, mmu-Hecw2_0009, mmu-Itgbl1_0002, mmu-Lrrc2_0005, mmu-Cpeb3_0007, mmu-Ryr2_0040, and mmu-Rtn4_0001) involved in cardiac hypertrophy and cardiac fibrosis were identified. We validated some key circRNAs by qPCR. The crucial coexpression of circRNA–mRNA and its interaction with miRNA showed the possible mechanism of circRNAs in the process of cardiac dysfunction. Our results may provide promising targets for the treatment of pathological cardiac hypertrophy and fibrosis. |
format | Online Article Text |
id | pubmed-9393479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93934792022-08-23 Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis Chen, Yan Zhou, Junteng Wei, Zisong Cheng, Yue Tian, Geer Quan, Yue Kong, Qihang Wu, Wenchao Liu, Xiaojing Front Pharmacol Pharmacology Cardiac hypertrophy initially serves as an adaptive response to physiological and pathological stimuli. Sustained hypertrophy progress to pathological cardiac hypertrophy, cardiac fibrosis and ultimately lead to heart failure, one of the leading medical causes of mortality worldwide. Intervention of pathological cardiac hypertrophy can effectively reduce the occurrence of heart failure. Abundant factors, such as adrenergic, angiotensin, and endothelin (ET-1) receptors, have been shown to participate in the regulation of pathological cardiac hypertrophy. Recently, an increasing number of studies have indicated that circRNA and circRNA-miRNA–mRNA network regulation is indispensable for the posttranscriptional regulation of mRNA in cardiac hypertrophy. In our study, the morphological, cardiac function and pathological changes during cardiac hypertrophy were investigated. RNA sequencing identified 93 circRNAs that were differentially expressed in the TAC_2w group, and 55 circRNAs in the TAC_4w group compared with the sham group. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses identified several significant pathways, including hypertrophic cardiomyopathy, extracellular matrix (ECM)-receptor interaction and focal adhesion. Coexpression analyses were performed for differentially expressed circRNAs and differentially expressed mRNAs. Based on gene set enrichment analysis (GSEA), 8 circRNAs (mmu-Nfkb1_0001, mmu-Smad4_0007, mmu-Hecw2_0009, mmu-Itgbl1_0002, mmu-Lrrc2_0005, mmu-Cpeb3_0007, mmu-Ryr2_0040, and mmu-Rtn4_0001) involved in cardiac hypertrophy and cardiac fibrosis were identified. We validated some key circRNAs by qPCR. The crucial coexpression of circRNA–mRNA and its interaction with miRNA showed the possible mechanism of circRNAs in the process of cardiac dysfunction. Our results may provide promising targets for the treatment of pathological cardiac hypertrophy and fibrosis. Frontiers Media S.A. 2022-08-08 /pmc/articles/PMC9393479/ /pubmed/36003513 http://dx.doi.org/10.3389/fphar.2022.940768 Text en Copyright © 2022 Chen, Zhou, Wei, Cheng, Tian, Quan, Kong, Wu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Chen, Yan Zhou, Junteng Wei, Zisong Cheng, Yue Tian, Geer Quan, Yue Kong, Qihang Wu, Wenchao Liu, Xiaojing Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title | Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title_full | Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title_fullStr | Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title_full_unstemmed | Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title_short | Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis |
title_sort | identification of circular rnas in cardiac hypertrophy and cardiac fibrosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393479/ https://www.ncbi.nlm.nih.gov/pubmed/36003513 http://dx.doi.org/10.3389/fphar.2022.940768 |
work_keys_str_mv | AT chenyan identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT zhoujunteng identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT weizisong identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT chengyue identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT tiangeer identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT quanyue identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT kongqihang identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT wuwenchao identificationofcircularrnasincardiachypertrophyandcardiacfibrosis AT liuxiaojing identificationofcircularrnasincardiachypertrophyandcardiacfibrosis |